ea0073aep823 | Late Breaking | ECE2021
Moustaki Melpomeni
, Kalogeris Nikolaos
, Katsafyloudi Maria
, Papanikola Nektaria
, Rigana Maria
, Spanou Loukia
, Angelopoulos Theodoros
, Kalantzis Ioannis
, Vryonidou Andromahi
IntroductionGlucagon-like peptide 1 receptor agonists (GLP-1RA) and sodium-glucose cotransporter-2 inhibitors (SGLT2i) are the two novel classes of anti-diabetic agents with compelling efficacy, in terms of glucose-lowering and cardio-renal protection. Euglycemic diabetic ketoacidosis (EDKA) is a serious rare adverse effect of SLT2i while the use of GLP-1RA has been scarcely linked with acute pancreatitis in humans.Case presentatio...